NCT05343507View on ClinicalTrials.gov

Ketamine to Treat Patients With Post-comatose Disorders of Consciousness

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

May 1, 2025

Study Completion Date

May 1, 2026

Conditions
Disorder of Consciousness
Interventions
DRUG

Ketalar 50 MG/ML Injectable Solution

Intravenous solution (other info already provided)

DRUG

Placebo

Saline Solution

Trial Locations (1)

1340

RECRUITING

Centre Hospitalier Neurologique William Lennox, Ottignies-Louvain-la-Neuve

All Listed Sponsors
collaborator

Centre Hospitalier Universitaire de Liege

OTHER

collaborator

William Lennox Neurological Center UCLouvain

UNKNOWN

lead

University of Liege

OTHER